For 25 years, the Walk to Defeat ALS® has brought together individuals and families impacted by ALS, offering hope, ...
Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 ...
Multiple system atrophy (MSA) is a rare neurological disorder that leads to the progressive deterioration of nerve cells in ...
About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting ...
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback